Home > Insider Trading > Filing (0000902664-15-000568)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1618561	Nexvet Biopharma Plc	NVET	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1163846	Adage Capital Partners, L.p.	200 Clarendon Street, 52Nd Floor Boston MA 02116	No	No	Yes	No
1165408	Adage Capital Partners Gp Llc	200 Clarendon Street, 52Nd Floor Boston MA 02116	No	No	Yes	No
1403403	Adage Capital Advisors, L.l.c.	200 Clarendon Street 52Nd Floor Boston MA 02116	No	No	Yes	No
1403404	Robert Atchinson	200 Clarendon Street 52Nd Floor Boston MA 02116	No	No	Yes	No
1403413	Phillip Gross	200 Clarendon Street 52Nd Floor Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, $0.0125 Nominal Value ("Ordinary Shares")	Acquisiton	2014-02-10	275,000	$10.00	275,000	No	4	P	Indirect	See footnotes
Ordinary Shares	Acquisiton	2014-02-10	600,000	$0.00	875,000	No	4	C	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes
No	4	C	Indirect	See footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Series B Preference Shares	Disposition	2014-02-10	600,000	$0.00	600,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

The securities to which this filing relates are held directly by Adage Capital Partners, L.P., a Delaware limited partnership (the "Fund"). Adage Capital Partners GP, L.L.C., a Delaware limited liability company ("ACPGP"), serves as the general partner of the Fund and as such has discretion over the portfolio securities beneficially owned by the Fund. Adage Capital Advisors, L.L.C., a Delaware limited liability company ("ACA"), is the managing member of ACPGP and directs ACPGP's operations. Robert Atchinson and Phillip Gross are the managing members of ACPGP and ACA and general partners of the Fund.
The filing of this statement shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
Reflects the automatic conversion of the Series B Preference Shares into Ordinary Shares on a one-for-one basis upon the completion of the initial public offering of Issuer's Ordinary Shares.